Search results for "FDA update"
Results 71 - 71 of about 71 for "FDA update".
Sort by:
Relevance
|
Newest
|
Oldest
First oral treatment approved for moderate to severe Crohn's disease
Upadacitinib (Rinvoq) is now approved to treat adult patients with moderately to severely active Crohn's disease who have had an inadequate response or intolerance to one or more tumor necrosis factor blockers.
https://gastroenterology.acponline.org/archives/2023/05/26/9.htm
26 May 2023